Cadence Minerals #KDNC – Further Director Share Purchases

Cadence (AIM:KDNC), the mining investment company, announces that on the 9 November the following directors purchased ordinary shares in the Company.  Director Position Number of ordinary shares acquired Price paid per share (£) Andrew Suckling Non-Executive Director 78,904 0.15 After these acquisitions, the total notifiable share interest in the Company for the directors is as […]

Power Metal Resources #POW Raises £26,250 Following Exercise of Warrants

Power Metal Resources PLC (LON:POW) the AIM listed metals exploration and development company is pleased to announce it has received a notice to exercise warrants over 3,750,000 new ordinary shares of 0.1 pence each in the Company. The Warrant Shares are being issued pursuant to the exercise of 3,750,000 at an exercise price of 0.7 pence […]

Cadence Minerals #KDNC – Director Share Purchases

Cadence (AIM:KDNC), the mining investment company, announces that on the 5 November the following directors purchased ordinary shares in the Company.  Director Position Number of ordinary shares acquired Price paid per share (£) Adrian Fairbourn Non-Executive Director 185,000 0.13 After these acquisitions, the total notifiable share interest in the Company for the directors is as […]

Power Metal Resources #POW – Raises £15,424 Following Exercise of Warrants

Power Metal Resources PLC (LON:POW) the AIM listed metals exploration and development company is pleased to announce it has received a notice to exercise warrants over 1,542,400 new ordinary shares of 0.1 pence each in the Company (“Warrant Shares”). The Warrant Shares are being issued pursuant to the exercise of 1,542,400 warrants at an exercise price […]

Power Metal Resources #POW – Australia Gold Joint Venture Update

Power Metal Resources plc (LON:POW) the AIM listed metals exploration and development company is pleased to provide an update from Red Rock Australasia Pty Ltd (“RRAL”), the Australian gold joint venture (“JV”) company in which POW has a 49.9% interest. Key points · RRAL has applied for an additional license application comprising 148 sq km of ground […]

Open Orphan #ORPH Announces New £2.5m Influenza Challenge Study Contract Win

Open Orphan plc (ORPH), a rapidly growing specialist CRO pharmaceutical services company which is the world leader in the testing of vaccines and antivirals using human challenge clinical trials is pleased to announce the signing of a £2.5 million contract by hVIVO, a subsidiary of Open Orphan, to conduct an Influenza human challenge study with […]